EP-100

DRUG2 trials

Sponsors

Esperance Pharmaceuticals Inc

Conditions

Advanced Solid TumorsOvarian Cancer RecurrentSolid Tumors

Phase 1

Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors

CompletedNCT00949559

Esperance Pharmaceuticals IncAdvanced Solid Tumors, Solid Tumors

Start: 2009-07-31End: 2012-03-31Updated: 2012-04-04

Phase 2

EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer

CompletedNCT01485848

Esperance Pharmaceuticals IncOvarian Cancer Recurrent

Start: 2012-02-29End: 2014-05-31Updated: 2014-06-10